Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-867-5 | CAS number: 111-41-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The LD50 value derived from the oral acute toxicity study with AEEA is 2150 mg/kg bw. The dermal LD50 was >2000 mg/kg bw. In two inhalation studies a LC0 value of 51.3 mg/m³ (saturated atmosphere) was established. The acute toxicity studies for the dermal and inhalative administration showed no mortality, only some weak clinical symptoms were noted.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Comparable to GLP guideline study with acceptable restrictions. Low purity of test substance.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: DR. K . THOMAE GMBH, D-7950 BIBERACH . FRG
- Age at study initiation: young adult
- Weight at study initiation: male: 181-191 g , female 169-179 g
- Fasting period before study: 16 h
- Housing: stainless steel wire mesh cages type DK-III (Becker & Co. Castrop-Rauxel. FRG)
- Diet: KLIBA-Labordiet FA. Klingentalmühle AG CH-4303 Kaiseraugst, Switzerland, ad libitum
- Water: tap water ad libitum
- Acclimation period: at least 1 week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24 °C
- Humidity (%): 30-70 %
- Photoperiod (hrs dark / hrs light): 12 h / 12 h
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 50 , 31.6 , 21.5 , 14.7 w/v
DOSE VOLUME APPLIED:
- 10 mL / kg (for all dose levels)
- Doses:
- 1470; 2150; 3160; 5000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: clinical signs were assessed at least once each work day and body weights were recorded on days 3, 5, 7 and 13
- other: check for moribund and dead animals was performed twice on workdays and once on holidays
- Necropsy of survivors performed: yes - Statistics:
- no data
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- ca. 2 150 mg/kg bw
- Remarks on result:
- other: calculated combined for males and females
- Mortality:
- please refer to "Remarks on results tables and figures"
- Clinical signs:
- other: Animals of both sexes receiving 3160 or 5000 mg/kg bw showed symptoms from 30 min until 4 hrs. after dosing. The symptoms included dyspnoea,apathy, staggering, and poor general state. Animals at 2150 mg/kg bw showed the same symptoms, but the onset (after
- Gross pathology:
- Necropsy revealed no abnormalities in animals that survived. In animals that died a general congestive hyperemia was noted. Stomach was found dilated with red liquid contents, hemorrhagic gastritis in animals at 5000 mg/kg bw. The intestines also contained red liquids, the mucosa of the
small intestine was often found deep-red. This is probably due to the caustic nature of AEEA. - Executive summary:
In this acute oral toxicity study (BASF AG, Department of Toxicology, 1986), groups of fasted, young adult wistar rats (5/sex) were given a single oral dose of AEEA (70 -85 % a.i.) in destilled water at doses of 1470, 2150, 3160 or 5000 mg/kg bw and observed for 14 days.
Oral LD50
Males = 2150 mg/kg bw
Females = 2380 mg/kg bw
Combined = 2150 mg/kg bw
Reference
Mortality was noted as follows:
|
|
|||
|
|
|||
Sex |
Dose Group [mg/kg bw] |
|||
|
1470 |
2150 |
3160 |
5000 |
|
|
|
|
|
Males |
0/5 |
3/5 |
5/5 |
5/5 |
Females |
0/5 |
1/5 |
5/5 |
5/5 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 150 mg/kg bw
- Quality of whole database:
- Comparable to Guideline study.
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study was performed prior to the implementation of GLP and OECD Guidelines, but is in compliance with the principles described in OECD Guideline 403. Observation period is not reported.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- not applicable
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- not specified
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- no data
- Route of administration:
- inhalation
- Type of inhalation exposure:
- whole body
- Vehicle:
- other: unchanged (no vehicle)
- Details on inhalation exposure:
- Several groups of usually 3 rats per sex were exposed sequentially to the vapors, generated by bubbling 200 l/h air through a substance column of about 5 cm above a fritted glass disc in a glass cylinder for different time periods ( 8 hours). The exposure time not causing lethality was usually testedtwice.
- Analytical verification of test atmosphere concentrations:
- no
- Duration of exposure:
- 8 h
- Concentrations:
- saturated atmosphere at 20 °C.
- No. of animals per sex per dose:
- 3 rats (total of 12 rats)
- Control animals:
- no
- Details on study design:
- - The animals were observed for signs of toxicity and mortality.
- Necropsy of survivors performed: yes - Sex:
- not specified
- Dose descriptor:
- LC0
- Effect level:
- 51.3 mg/m³ air
- Exp. duration:
- 8 h
- Remarks on result:
- other: saturated atmosphere
- Mortality:
- No mortality (0/12) was seen.
- Gross pathology:
- Apart from strong eye irritation no findings were noted at necropsy.
- Other findings:
- - Other observations: Animals tried to escape upon start of exposure.
- Executive summary:
In this acute inhalation toxicity study a total of 12 rats (two times 3/sex) were whole body exposed to AEEA (saturated atmosphere at 20 °C) for 8 hours. Animals then were observed. Animals tried to escape upon start of exposure. No mortality occured. Apart from strong eye irritation no findings were noted at necropsy.
Reference
Animals were exposed to AEEA in a saturated atmosphere at 20 °C. No exposure concentration was reported. As the vapour pressure of AEEA is 0.012 hPa at 20 °C (calculated), a saturated atmosphere corresponds to 51.3 mg/m³.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating conc.
- Value:
- 51.3 mg/m³ air
- Quality of whole database:
- Study was performed prior to the implementation of GLP and OECD Guidelines, but is in compliance with the principles described in OECD Guideline 403.
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: SPF-Breed, Wiga, Sulzfeld, Germany
- Age at study initiation: young adult
- Weight at study initiation: male: 145 g , female 127 g
- Diet: concentrated feed, Eggersmann, Rinteln/Weser, Germany, ad libitum
- Water : tap water ad libitum - Type of coverage:
- occlusive
- Vehicle:
- other: applied in olive oil and as neat substance
- Details on dermal exposure:
- TEST SITE
- Area of exposure: 11.5 cm² of the intact dorsal skin clipped 24 h before treatment
- coverage: 100 %
- Type of wrap if used: inert foil
REMOVAL OF TEST SUBSTANCE
- Washing: after 24 h with warm water
- Duration of exposure:
- 24 h
- Doses:
- 400 mg/kg bw (olive oil), 2000 mg/kg bw (neat)
- No. of animals per sex per dose:
- 10/10 and 5/5 (males/females) for the 400 and 2000 mg/kg bw dose levels, respectively
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: the animlas were observed for signs of toxicity during the 14-day observation ( after observation period animals were sacrified and necropsied)
- Necropsy of survivors performed: yes - Statistics:
- no data
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Mortality:
- - no mortality was seen at either dose level
- Clinical signs:
- other: - no signs of systemic toxicity were seen at either dose level
- Gross pathology:
- - during terminal necropsy pale kidneys were occasionally noted
- local skin irritation was noted 24 hours after application which led to scar formation within 14 days - Executive summary:
In this acute dermal toxicity study groups of young adult Sprague Dawley rats were dermally exposed to AEEA (> 98 % a.i) at doses of 400 (in olive oil, 10/sex) and 2000 mg/kg bw (neat substance, 5/sex) for 24 hours to an area of 11.5 cm². Animals then were observed for 14 days. During terminal necropsy pale kidneys were occasionally noted and local skin irritation was noted 24 hours after application which led to scar formation within 14 days. No mortality and no signs of systemic toxicity were seen at either dose level.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- Guideline study
Additional information
Oral route:
In a acute oral toxicity study (BASF AG, Department of Toxicology, 1986), groups of fasted, young adult wistar rats (5/sex) were given a single oral dose of AEEA (70 -85 % a.i.) in destilled water at doses of 1470, 2150, 3160 or 5000 mg/kg bw and observed for 14 days.
Oral LD50
Males = 2150 mg/kg bw
Females = 2380 mg/kg bw
Combined = 2150 mg/kg bw
Inhalation route:
In an acute inhalation toxicity study (BASF AG, Department of Toxicology, 1970) a total of 12 rats (two times 3/sex) were whole body exposed to AEEA (saturated atmosphere at 20 °C) for 8 hours. Animals then were observed. Animals tried to escape upon start of exposure. No Mortality occured. Apart from strong eye irritation no findings were noted at necropsy.
In another acute inhalation toxicity study (Myers RC & Ballantyne B, 1997), groups of 6 young adult female Wistar rats were exposed by inhalation route to AEEA for 6 -8 hours (saturated atmosphere, whole body). Animals then were observed for 14 days. During the observationperiod weight gain was normal, and no mortality occured. Necropsy showed no gross findings. In both studies a LC0 value of 51.3 mg/m³ (saturated atmosphere) was established.
Dermal route:
In an acute dermal toxicity study (BASF AG, Department of Toxicology, 1980) groups of young adult Sprague Dawley rats were dermally exposed to AEEA (>98 % a.i) at doses of 400 (in olive oil, 10/sex) and 2000 mg/kg bw (neat substance, 5/sex) for 24 hours to an area of 11.5 cm². Animals then were observed for 14 days. During terminal necropsy pale kidneys were occasionally noted and local skin irritation was noted 24 hours after application which led to scar formation within 14 days. No mortality and no signs of systemic toxicity were seen at either dose level.
Justification for selection of acute toxicity – oral endpoint
The Key study (BASF AG, 1986) was selected.
Justification for selection of acute toxicity – inhalation endpoint
The Key study (BASF AG, 1970) was selected.
Justification for selection of acute toxicity – dermal endpoint
The Key study (BASF AG, 1980) was selected.
Justification for classification or non-classification
Based on the results of the acute oral, dermal and inhalation key toxicity studies, AEEA is not subjected to classification and labelling for acute toxic effects according to Directive 67/548/EEC and Regulation 1272/2008/EC.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.